UnitedHealth Group (UNH) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

UnitedHealth Group

NYSE: UNH · Real-Time Price · USD
360.28
6.56 (1.85%)
At close: Oct 03, 2025, 3:59 PM
360.60
0.09%
After-hours: Oct 03, 2025, 07:58 PM EDT

UnitedHealth Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
422.82B 410.06B 400.28B 393.9B 385.44B 379.49B 371.62B 359.98B 348.51B 335.94B 324.16B 315.12B 306.56B 297.55B 287.6B 279.32B 272.1B 262.92B
Cost of Revenue
334.69B 319.89B 310.88B 303.81B 294.99B 288.2B 280.66B 270.14B 262.11B 252.78B 244.54B 238.8B 232.96B 226.48B 217.94B 211.49B 205.96B 193.93B
Gross Profit
88.12B 90.17B 89.4B 90.09B 90.45B 91.28B 90.96B 89.84B 86.4B 83.16B 79.62B 76.32B 73.6B 71.07B 69.65B 67.83B 66.14B 68.99B
Operating Income
30.75B 33.48B 32.29B 32.2B 32.02B 32.2B 32.36B 31.56B 30.5B 29.57B 28.43B 27.09B 25.34B 24.18B 23.97B 21.95B 20.89B 24.15B
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
26.59B 28.18B 20.07B 20.14B 20.22B 21.78B 29.11B 28.47B 27.72B 27.16B 26.34B 25.24B 23.58B 22.48B 22.31B 20.32B 19.28B 22.52B
Net Income
21.3B 22.11B 14.4B 14.32B 14.1B 15.36B 22.38B 21.69B 21.11B 20.7B 20.12B 19.43B 18.25B 17.45B 17.29B 15.43B 14.51B 16.88B
Selling & General & Admin
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Research & Development
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Expenses
57.37B 56.69B 57.11B 57.89B 58.43B 59.08B 58.6B 58.28B 55.91B 53.59B 51.18B 49.23B 48.26B 46.89B 45.68B 45.88B 45.26B 44.84B
Operating Expenses
57.37B 56.69B 57.11B 57.89B 58.43B 59.08B 58.6B 58.28B 55.91B 53.59B 51.18B 49.23B 48.26B 46.89B 45.68B 45.88B 45.26B 44.84B
Interest Expense
4.1B 4.06B 3.91B 3.73B 3.49B 3.34B 3.25B 3.09B 2.77B 2.41B 2.09B 1.85B 1.75B 1.7B 1.66B 1.63B 1.6B 1.62B
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
392.07B 376.58B 367.99B 361.69B 353.42B 347.28B 339.26B 328.42B 318.02B 306.37B 295.73B 288.03B 281.23B 273.37B 263.63B 257.38B 251.21B 238.77B
Income Tax Expense
4.5B 5.24B 4.83B 5.01B 5.3B 5.63B 5.97B 6.09B 6B 5.89B 5.7B 5.32B 4.85B 4.58B 4.58B 4.42B 4.32B 5.24B
Shares Outstanding (Basic)
910M 918M 927M 923M 921M 920M 924M 926M 930M 932M 934M 935M 935M 939M 941M 942M 943M 944M
Shares Outstanding (Diluted)
910M 918M 927M 930M 928M 922M 935M 936M 940M 943M 947M 948M 950M 954M 955M 955M 956M 957M
EPS (Basic)
23.19 24.03 15.59 15.51 15.26 16.57 24.12 23.32 22.64 22.17 21.50 20.73 19.44 18.54 18.34 16.35 15.35 17.82
EPS (Diluted)
23.08 23.88 15.50 15.35 15.08 16.36 23.84 23.04 22.35 21.87 21.19 20.42 19.15 18.27 18.08 16.12 15.14 17.59
EBITDA
34.92B 36.4B 28.08B 27.9B 27.71B 29.12B 36.33B 35.54B 34.3B 33.15B 31.84B 30.27B 28.49B 27.31B 27.07B 25.01B 23.87B 27.07B
EBIT
30.7B 32.24B 23.98B 23.87B 23.71B 25.12B 32.36B 31.56B 30.5B 29.57B 28.43B 27.09B 25.34B 24.18B 23.97B 21.95B 20.89B 24.15B
Depreciation & Amortization
4.23B 4.16B 4.1B 4.03B 4B 4B 3.97B 3.98B 3.8B 3.58B 3.4B 3.19B 3.16B 3.13B 3.1B 3.06B 2.99B 2.93B